FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular to a method for treating a patient with cancer expressing the folic acid receptor 1 (FOLR1), including the administration of an immunoconjugate that binds to FOLR1, as well as bevacizumab, carboplatin or pegidated liposomal doxorubicin (PLD) to a specified patient in need thereof. A method for treating a patient with FOLR1-expressing cancer is also disclosed, including the administration of an immunoconjugate that binds to FOLR1, as well as bevacizumab, bevacizumab and pegylated liposomal doxorubicin (PLD) or carboplatin and pegylated liposomal doxorubicin to a specified patient in need thereof.
EFFECT: invention can be effectively used in combination therapies targeting FOLR1-expressing tumor cells for the treatment of cancer.
36 cl, 12 dwg, 4 tbl, 13 ex
| Title |
Year |
Author |
Number |
| ANTI-FOLR1 IMMUNOCONJUGATE APPLICATION SCHEMES |
2014 |
- Latz, Robert Dzh.
- Ponte, Khose
|
RU2801307C1 |
| ANTI-FOLR1 IMMUNOCONJUGATE DOSING REGIMENS |
2014 |
- Latz Robert Dzh.
- Ponte Khose
|
RU2696579C2 |
| METHOD FOR TREATMENT OF MALIGNANT NEOPLASM, USING COMBINATION OF ANTIBODY TO PD-1 AND CHEMOTHERAPEUTIC AGENT |
2021 |
- Shustova Mariya Stanislavovna
- Fogt Sergej Nikolaevich
- Kryukov Fedor Borisovich
- Morozov Dmitrij Valentinovich
|
RU2787457C2 |
| ANTIBODIES AND ANALYSIS METHODS FOR FOLIC ACID 1 RECEPTOR DETECTION |
2014 |
- Eb Olga
- Tavares Deniel
- Setiadi Dzhulianto
- Ledd Sherron
- Karrigan Kristina N.
- Rui Linyun
|
RU2725825C2 |
| THERAPY OF METASTATIC UROTHELIAL CANCER USING ANTIBODY-DRUG CONJUGATE SATSITUZUMAB GOVITECAN (IMMU-132) |
2017 |
- Govindan Serengulam V.
- Goldenberg David M.
|
RU2757395C2 |
| TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER CHARACTERIZED BY Trop-2 EXPRESSION USING SATSITUZUMAB GOVITECAN AND Rad51 INHIBITOR |
2018 |
- Cardillo Thomas M.
- Goldenberg David M.
|
RU2758234C2 |
| METHODS OF TREATING CANCER USING ANTAGONISTS BINDING TO COMPONENTS OF THE SIGNAL PATH PD-1, AND TAXANES |
2014 |
|
RU2719487C2 |
| METHODS OF TREATING USING ANTI-CD123 IMMUNOCONJUGATES |
2019 |
- Tsvajdler-Makkej, Patrik
- Kalm-Merdek, Kerri
- Sloss, Kallum
- Romanelli, Enzhela
|
RU2816847C2 |
| DIAGNOSTIC ANALYSES AND KITS FOR DETECTION OF FOLATE RECEPTOR 1 |
2018 |
- Teste, Netan E.
- Karrigan, Kristina N.
- Eb, Olga
- Tavares, Deniel
- Vulf, Beni B.
|
RU2788126C2 |
| STABLE COMPOSITIONS OF IMMUNOCONJUGATES CONTAINING ANTIBODIES TO CD79b |
2019 |
- Patel, Ankit R.
- Lyu, Tszyun
|
RU2800803C2 |
